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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARYIn regeneration-competent vertebrates, such as salamanders, regeneration depends on the ability of various differentiated adult cell types
to undergo natural reprogramming. This ability is rarely observed in regeneration-incompetent species such as mammals, providing an
explanation for their poor regenerative potential. To date, little is known about themolecularmechanismsmediating natural reprogram-
ming during regeneration. Here, we have identified the extent of extracellular signal-regulated kinase (ERK) activation as a key compo-
nent of suchmechanisms.We show that sustained ERK activation following serum induction is required for re-entry into the cell cycle of
postmitotic salamandermuscle cells, partially by promoting the downregulation of p53 activity. Moreover, ERK activation induces epige-
netic modifications and downregulation of muscle-specific genes such as Sox6. Remarkably, while long-term ERK activation is found in
salamander myotubes, only transient activation is seen in their mammalian counterparts, suggesting that the extent of ERK activation
could underlie differences in regenerative competence between species.INTRODUCTION
In most vertebrates, the process of myogenic differentia-
tion entails the withdrawal of precursors from the cell
cycle, followed by their fusion into myotubes. The multi-
nucleate state is characterized by a permanent postmitotic
arrest, which renders the myotubes unable to respond to
proliferative cues (Pajalunga et al., 2008; Walsh and Perl-
man, 1997). In contrast, salamander myotubes remain
responsive to such cues, being able to re-enter the cell cycle
upon serum stimulation in culture (Tanaka et al., 1997) or
after implantation within regenerating structures (Kumar
et al., 2000).
In salamander (Notophthalmus viridescens) A1 myotubes
(Ferretti and Brockes, 1988), serum stimulation induces a
reprogramming process that includes partial dedifferentia-
tion, as suggested by the downregulation of the myogenic
geneMyf5 (Imokawa et al., 2004), and re-entry into the cell
cycle, which is also considered an aspect of dedifferentia-
tion. The latter depends on the phosphorylation of Rb
(Tanaka et al., 1997) and the downregulation of p53 activ-
ity (Yun et al., 2013). The serum component that triggers
these responses is not a conventional growth factor but
an as-yet-unidentified thrombin-activated serum compo-
nent that acts as a mitogen for myotubes, but not for
mononucleate precursors (Lo¨o¨f et al., 2007; Straube et al.,
2004; Tanaka et al., 1999). Even though mammalian myo-
tube nuclei cannot be reprogrammedupon exposure to this
factor (Lo¨o¨f et al., 2007), they are able to re-enter the cell
cycle after forming heterokaryons with salamander myo-
tubes (Velloso et al., 2001). This suggests that even whenthe initial response may be different, part of the pathway
leading to serum-mediated reprogramming is conserved.
Both the identity of the serum factor and the signaling
pathways driving the reversal of the differentiated state
in regeneration-competent salamander cells remain un-
known, although extensive efforts to identify the serum
factor are ongoing (Straube et al., 2004).
In proliferating cells, the extracellular signal-regulated
kinase (ERK) family of mitogen-activated protein kinases
(MAPKs) plays a critical role in driving cell-cycle progres-
sion in a variety of cell types (Albeck et al., 2013; Cook
and McCormick, 1996; Murphy et al., 2002; Weber et al.,
1997; Yamamoto et al., 2006). In fibroblasts, sustained
ERK activation is required for successful S phase progres-
sion by promoting the downregulation of antiproliferative
genes during G1 phase and controlling the state of Rb
phosphorylation (Yamamoto et al., 2006). Hence, it is
possible that ERK activation plays a role during the reprog-
ramming of differentiated salamander cells. Herein, we
have tested this hypothesis using the salamander A1 cell
line as a model for serum-induced reprogramming.RESULTS AND DISCUSSION
Sustained ERK Activation in Cell-Cycle Re-entry of
Salamander Myotubes
Serum stimulation of A1 myotubes triggers an early activa-
tion of the ERK pathway, which is sustained for up to 48 hr
post stimulation (Figures 1A and 1B). This is accompanied
by a long-term increase in the protein levels of c-FOSStem Cell Reports j Vol. 3 j 15–23 j July 8, 2014 j ª2014 The Authors 15
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ERK Activation in Reprogramming(Figure S1 available online), a sensor for ERK signal dura-
tion (Murphy et al., 2002). Other MAPK pathways are
also activated, albeit to a lesser extent, including the
stress-related MAPKs c-Jun N-terminal kinase (JNK) and
p38 (Figures 1A, 1B, and S1). Therefore, we asked whether
any of these pathways are required for myotube S phase
re-entry following serum stimulation. The administration
of specific inhibitors of ERK (U0126), JNK (SP600125),
and p38 (506126) kinase activation (Figure S1), alongside
serum stimulation, leads to differential disruption of both
Rb phosphorylation (Figures 1C and S1) and S phase re-
entry (Figures 1D and S1) depending on the targeted
pathway. Inhibition of the JNK pathway leads to a 50%
reduction in both myotube Rb phosphorylation and S
phase re-entry, while disruption of the p38 MAPK not
only does not impair these processes but also significantly
enhances cell-cycle re-entry (Figure 1D). Remarkably, the
inhibition of ERK signaling severely impairs both pro-
cesses, suggesting that the activation of the ERK pathway is
critical for the cell-cycle re-entry of salamander myotubes.
In a variety of mammalian contexts, it is the sustained
activation of ERK signaling that promotes cell proliferation
(Page`s et al., 1993; Weber et al., 1997; Yamamoto et al.,
2006). To test whether sustained ERK activation mediates
the cell-cycle aspects of salamander myotube reprogram-
ming, we incubated A1 myotubes with serum and in-
hibited ERK signaling at different times post stimulation
(Figure 1E). ERK inhibition, even at 24 hr post stimulation,
has a negative effect on Rb phosphorylation (Figure 1F).
This suggests that the sustained, but not transient, activa-
tion of the ERK pathway is necessary for cell-cycle re-entry
of salamander myotubes.
Several isoforms of ERK MAPKs exist, with ERK1 and its
close relative ERK2 mediating cell-cycle progression in a
variety of cell types (Yang et al., 2013). The ERK inhibitorFigure 1. Sustained ERK Activation Is Necessary for Cell-Cycle Re
Myotubes
(A) Western blot analysis of A1 myotube extracts pre (0.25% FCS) or
(B) Western blot quantification of phospho protein levels, relative to b
induction.
(C) Quantification of myotubes exhibiting phosphorylated Rb, followi
the indicated compounds.
(D) Quantification of bromodeoxyuridine (BrdU)-positive myotubes,
following a BrdU pulse.
(E) Schematic representation of myotube treatments to test the effe
(F) ERK inhibition at different times after serum induction affects Rb
72 hr. ** refers to significant differences between 72 hr and 24 hr m
(G–I) Serum-induced Rb phosphorylation (G) and myotube S phase re-
combined treatment. Insets correspond to Rb phosphorylation (G)
treatments. (I) In situ hybridization against the p53 target gene Ga
myotubes following serum induction.
Values represent the mean ± SD (B) or mean ± SEM (C–H) (*p < 0.05,
indicates the number of independent experiments. Scale bar in (I) reused in this study inhibits the activation of ERK1/2 but
can also have effects on ERK5/big MAPK 1 (BMK1)
signaling (Kamakura et al., 1999). Hence, we used a specific
BMK1 inhibitor to dissect which of the ERK MAPK path-
ways mediates the myotube response to serum. As seen in
Figures 1C and 1D, the inhibition of BMK1 does not impair
Rb phosphorylation or S phase re-entry but significantly
enhances these processes. While the general ERK inhibitor
decreases S phase re-entry in both myotubes and mononu-
cleates, the BMK1 inhibitor has a negative effect on mono-
nucleates but a positive one on myotubes (Figures 1 and
S1). This suggests that activation of both ERK1/2 and
ERK5 is required for the proliferation of mononucleates
but only ERK1/2 activation is necessary for S phase re-entry
in myotubes. The positive effect of BMK1 inhibition on
myotube cell-cycle re-entry is likely due to its negative
effect on mononucleate proliferation, as it is known that
the percentage of myotubes in S phase is inversely propor-
tional to the amount of mononucleates in their vicinity
(Tanaka et al., 1997). Indeed, the inhibition of BMK1 com-
bined with the addition of 30% confluent mononucleates
abrogates the effect of ERK5 inhibition and impairs myo-
tube S phase re-entry (Figure S1).
Sustained activation of ERK signaling has been shown to
promote the downregulation of Gadd45, a classical p53
target (Yamamoto et al., 2006). Furthermore, we have
recently shown that the downregulation of p53 activity is
a critical step during A1 myotube cell-cycle re-entry (Yun
et al., 2013). To test whether p53 downregulation is pro-
moted by ERK signaling, we compared the effects on Rb
phosphorylation and S phase re-entry caused by the stabi-
lization of p53 using nutlin3a (Vassilev et al., 2004), the in-
hibition of ERK activation, or a combination of both. All
three treatments affected both processes equally (Figures
1G and 1H) at the mononucleate or myotube level,-entry of Differentiated, Regeneration-Competent Salamander
post serum induction.
-actin, showing the kinetics of ERK and JNK activation upon serum
ng immunostaining 48 hr after serum induction, in the presence of
as measured by immunostaining at 72 hr post serum induction,
ct of ERK inhibition in cell-cycle re-entry.
phosphorylation in myotubes, as determined by immunostaining at
easurements.
entry (H) are impaired by p53 stabilization, ERK inhibition, or their
or cell-cycle re-entry (H) in myotubes exposed to the indicated
dd45. ERK inhibition impairs the downregulation of Gadd45 in A1
**p < 0.01); n = 4 (B, F, and I) and n = 5 (C, D, G, and H), where n
presents 40 mm.
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activation of ERK signaling form part of the same pathway.
We additionally observed that while treatment of myo-
tubes with the p53 inhibitor a-pifithrin did not affect Rb
phosphorylation or cell-cycle re-entry, the combined inhi-
bition of ERK signaling and p53 had a negative effect on
this processes. However, the joint inhibition of ERK and
p53 significantly increased the percentage of myotubes
positive for Rb phosphorylation and re-entering the cell
cycle, when compared with the inhibition of ERK signaling
on its own (Figures 1G and 1H). This suggests that ERK
signaling is required for cell-cycle re-entry by, at least in
part, promoting the downregulation of p53 activity. To
test this further, we investigated the effect of inhibiting
different MAPKs on the regulation of Gadd45 gene expres-
sion by in situ hybridization. ERK inhibition abrogated the
downregulation of Gadd45 induced by serum stimulation
(Figure 1I), suggesting that the activation of the ERK
pathway promotes cell-cycle re-entry in salamander myo-
tubes by downregulating p53 activity.
ERK Activation Promotes Phenotypic Changes in
Salamander Myotubes
A second aspect of the response to serum stimulation in sal-
amander myotubes is the promotion of transcriptional
changes that lead to partial dedifferentiation. As ERK acti-
vation is required at such an early stage of the response, it
is plausible that it contributes to the promotion of dediffer-
entiation as well as cell-cycle progression. To address this
possibility we cloned the newt homolog of the muscle-spe-
cific gene Sox6 (Hagiwara et al., 2007) (Figure S2) and exam-
ined its expression in purified myotube cultures. While
serum stimulation leads to a 50% reduction of the relative
levels of Sox6 (Figure 2A), ERK inhibition abrogates this
effect, suggesting that the downregulation of Sox6 upon
serum stimulation is dependent on ERK activation. This
observation is consistent with a previous study suggesting
that ERK activation drives the dedifferentiation of rodent
Schwann cells (Harrisingh et al., 2004). While the expres-
sion of Sox6 changed upon serum stimulation, we did not
detect any changes in the protein levels of muscle-specific
myosin heavy chain under similar conditions (Figure 2C).
This is consistent with the notion that serum promotes a
limited dedifferentiation process in regeneration-compe-
tent salamander myotubes.
Furthermore, we noticed that there are large-scale epige-
netic changes in the A1 myotubes following serum stimu-
lation. Immunostaining against the repressive histone
mark dimethyl H3K9 (Jenuwein and Allis, 2001) revealed
a decrease in signal intensity in myotubes upon serum
stimulation, consistent with previous observations (Lo¨o¨f
et al., 2007). Interestingly, this decrease is abrogated only
by ERK, but not by JNK or BMK1 inhibition (Figure 2B).18 Stem Cell Reports j Vol. 3 j 15–23 j July 8, 2014 j ª2014 The AuthorsWestern blot analysis of purified myotube extracts indi-
cates that there is a 50% decrease in dimethyl H3K9 upon
serum stimulation but only a 20% decrease when ERK
signaling is inhibited (Figure 2C). This is particularly inter-
esting for two reasons. First, the demethylation of H3K9 at
E2F-regulated promoters is required for the progression
into S phase (Ogawa et al., 2002). Second, H3K9 demethy-
lation is required for the expression of pluripotency-associ-
ated genes and the maintenance of embryonic stem cells
(Loh et al., 2007).
In the light of these observations, it is possible that the
changes in H3K9 demethylation, which we show to be
dependent on ERK activation, generate a favorable envi-
ronment for altering gene expression in the direction of
partial dedifferentiation and cell-cycle progression in
regeneration-competent cells.
Lack of Sustained ERK Activation in Regeneration-
Incompetent Mammalian Myotubes
While salamander myotubes are able to respond to serum
stimulation by promoting a signaling cascade leading to
partial dedifferentiation and cell-cycle re-entry, mamma-
lian myotubes are unable to do so (Tanaka et al., 1997).
Nevertheless, the latter appear to have retained some
responsiveness, as serum stimulation (Tiainen et al.,
1996) or incubation with partially purified serum factor
preparations (Lo¨o¨f et al., 2007) leads to the upregulation
of immediate-early proliferative response genes such as
c-fos. However, the subsequent steps in the pathway lead-
ing to reprogramming do not take place. In the light of
our observations, this suggests that altered or absent ERK
activation could underlie the lack of responsiveness found
in mammalian myotubes.
We explored this possibility using the murine myogenic
cell line Pmi28 (Figure 3A), which can be induced to form
myotubes that cannot dedifferentiate or re-enter the cell
cycle upon serum stimulation (Duckmanton et al.,
2005). Remarkably, we found that serum stimulation of
Pmi28 myotubes leads to transient ERK1/2 activation,
which peaks at 1 hr post induction and returns to baseline
in approximately 3 hr (Figures 3B and 3C). In this system,
the intensity of ERK activation is considerably lower
than in the induced salamander myotubes (Figure 3C).
Furthermore, unlike A1 myotubes, stimulated Pmi28
myotubes do not activate JNK and do not exhibit any
changes in the total amounts of the repression marker
dimethyl H3K9 (Figure 3D). However, serum stimulation
promotes the upregulation of c-FOS and an increase in
cyclin D1 and D3, which depend on the transient activa-
tion of ERK (Figures 3D and 3E). This suggests that the
transient response to serum previously observed in
mammalian myotubes is mediated by ERK signaling.
Nonetheless, consistent with previous observations (Lo¨o¨f
Figure 2. ERK Activation Leads to Downregulation of Muscle-Specific Gene Expression and Promotes Epigenetic Changes during
Reprogramming of Salamander Myotubes
(A) Left: schematic representation of the variation in Sox6mRNA levels upon myogenic differentiation. Right: quantitative RT-PCR analysis
of Sox6 (with two different primers, Sox6 1 and Sox6 2) in RNA extracts from purified A1 myotubes, normalized to Ef1-a or L27.
(B) Representative images of myotubes following immunostaining against dimethylated H3K9 and myosin heavy chain (MyHC) 1.5 days
after the indicated treatments. Scale bar represents 50 mm.
(C) Western blot analysis of purified myotube extracts. Note the decrease in dimetH3K9 upon serum induction and its impairment when ERK
signaling is inhibited. The relative amount of dimethylated H3K9 was quantified for the indicated treatments.
Values represent the mean ± SEM (*p < 0.05); n = 4 (A–C), where n indicates the number of independent experiments.
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changes in late proliferative genes such as Cyclin E2 and
PCNA (Figure 3E). Together, these observations suggestthat the extent of ERK signaling could underlie differences
in regenerative capabilities between salamander and
mammalian cells.Stem Cell Reports j Vol. 3 j 15–23 j July 8, 2014 j ª2014 The Authors 19
Figure 3. Regeneration-Incompetent Mammalian Myotubes Do Not Trigger Sustained ERK Activation upon Serum Stimulation
(A) Representative image of Pmi28 myotubes 3 days after myogenesis. Nuclei are stained with Hoechst 33258 (blue). Scale bar represents
100 mm.
(B, C, and E) Western blot analysis of Pmi28 myotube extracts pre (6% HS) or at different times after induction with 20% FCS.
(D) Differential kinetics of ERK activation in mammalian versus salamander myotubes at different times after serum induction following
western blot quantification of relative levels of phosphorylated ERK.
(F) Western blot analysis of whole-cell extracts from myotubes overexpressing pnGFPN2 (GFPN2), MEK1-R4F (R4F), and
MEK1S218E/S222D(SE/SD). The relative amount of c-fos and PCNA was quantified for the indicated treatments.
(G) A model for the role of ERK1/2 activation during serum-induced reprogramming of regeneration-competent salamander myotubes
compared to their mammalian counterparts.
Values represent the mean ± SD (*p < 0.05, **p < 0.01); n = 4 (B–F), where n indicates the number of independent experiments.
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ERK activation could promote cell-cycle re-entry in this sys-
tem. Overexpression of two different constitutively active
ERK activator kinase 1 (MEK1) mutants, MEK1-R4F and
MEK1S218E/S222D (Mansour et al., 1994), does not lead to S
phase re-entry in Pmi28 myotubes. Such failure in promot-
ing cell-cycle progression could be attributed to the lack of
coactivation of other MAPKs (e.g., JNK), the presence of
epigenetic factors in mammalian myotubes that stabilize
the differentiated state, or the intrinsic limitations of the
overexpression system, which does not permit an exact
mimicry of the required kinetics of ERK activation. How-
ever, constitutive ERK activation by overexpression of the
MEK1 mutants does promote an increase in the protein
levels of c-FOS and, importantly, the late proliferative
gene PCNA (Figure 3F). These changes could result from
either the sustained activation of ERK signaling or the tran-
sient elevation of phosphorylated ERK (pERK) levels upon
constitutive expression of the mutants. The induction of
untransfected Pmi myotubes with 20% serum leads to a
pERK/ERK ratio of 0.87 ± 0.13. In contrast, the overexpres-
sion of MEK1-R4F and MEK1S218E/S222D leads to lower
pERK/ERK ratios (0.34 ± 0.05 and 0.53 ± 0.07, respectively,
corrected for total protein load); however, these are sus-
tained over time. Hence, our results suggest that the
promotion of sustained ERK activation can further the pro-
gression of the cell-cycle re-entry program in mammalian
myotubes.
A Model for the Role of ERK Signaling during the
Reprogramming of Postmitotic Differentiated Cells
We propose that in regeneration competent salamander
myotubes—and possibly other cell types—an as-yet-
unidentified thrombin-activated serum factor triggers sus-
tained activation of ERK signaling (Figure 3G). Such
activation leads to the downregulation of p53 activity,
which facilitates cell-cycle re-entry via Rb phosphoryla-
tion, and promotes alterations in the gene expression land-
scape that could favor both partial dedifferentiation and
cell-cycle re-entry. ERK activation could also crosstalk
with the JNK and p38 stress-related signaling cascades,
for example by modulating the apoptotic response medi-
ated by these kinases. In contrast, regeneration-incompe-
tent mammalian cells are incapable of inducing sustained
ERK activation, most likely due to a lack of an upstream
receptor or signaling component, and are therefore unable
to undergo reprogramming.
In this study, we show that sustained ERK activation is
required for the promotion of phenotypic changes sugges-
tive of partial dedifferentiation and, critically, for cell-cycle
re-entry in salamander myotubes. It remains an issue
whether other muscle-specific genes are downregulated
upon serum stimulation and whether this partial dediffer-entiation is dependent on cell-cycle re-entry. In this regard,
an earlier study showed that cellularization (Velloso et al.,
2000), another index of dedifferentiation, proceeds in the
absence of cell-cycle re-entry. Further studies should deter-
mine the connection between these processes.
It is particularly interesting that a similar mechanism to
that used by proliferating cells following standard growth
factor stimulation (sustained ERK signaling) is activated
during salamander myotube reprogramming, as the serum
factor responsible for triggering this process is not one of
the conventional growth factors known to promote prolif-
eration in undifferentiated cells (Straube et al., 2004;
Tanaka et al., 1999). Indeed, the inhibition of fibroblast
growth factor (FGF) and VEGF, growth factors that elicit
sustained ERK1/2 signaling in a range of proliferating cell
types, does not perturb either ERK1/2 or Rb phosphoryla-
tion in purified myotubes (Figure S3). Nevertheless, the
use of a general receptor tyrosine kinase inhibitor abrogates
ERK, JNK, and Rb phosphorylation following serum stimu-
lation, suggesting that a receptor tyrosine kinase is required
for the initiation of the reprogramming response. This un-
identified RTK may be a target, direct or indirect, of the
thrombin-activated serum factor. Further efforts should
focus on defining the nature of both the serum factor as
well as the RTK, so as to gain a better understanding of
the mechanisms regulating the plasticity of the differenti-
ated state in regeneration-competent cells and eventually
apply this knowledge in a clinical setting.CONCLUSIONS
Together, our results suggest that the ability to trigger
sustained ERK activation may underlie species-specific dif-
ferences in the generation of cells of regenerative potential.
Furthermore, they suggest that current approaches to
induce regenerative potential in mammalian systems
should consider the manipulation of MAPK signaling,
with a focus on the promotion of ERK activation.EXPERIMENTAL PROCEDURES
Cell Culture
A1 cells were previously derived from newt (N. viridescens) limb
mesenchyme (Ferretti and Brockes, 1988). The cells were grown
on 0.75% gelatine-coated plastic dishes in minimal essential
medium (Gibco) supplemented with 10% heat-inactivated fetal
calf serum (FCS; Gibco), 25% H2O, 2nM L-glutamine (Gibco),
10 mg/ml insulin (Sigma), and 100 U/ml penicillin/ streptomycin
(Gibco) in a humidified atmosphere of 2.5% CO2 at 25
C. Routine
cell subculture was performed as previously described (Lo et al.,
1993).
Pmi28 cells were a kind gift from A. Starzinski-Powitz (Goethe
Universita¨t, Germany). Mouse Pmi28 cells were grown onStem Cell Reports j Vol. 3 j 15–23 j July 8, 2014 j ª2014 The Authors 21
Stem Cell Reports
ERK Activation in ReprogrammingBIOCOAT I T-75 flasks (Becton-Dickinson) in F-10 (HAM) media
supplemented with 20% FCS (Gibco) and 100 U/ml penicillin/
streptomycin (Gibco) in a humidified atmosphere of 6% CO2 at
37C. Cells were passaged at a 1:10 ratio every 3 days.
Myotube Formation Assay
Myogenesis was induced in confluent A1 cells by lowering the
fetal calf serum concentration from 10% to 0.25%. Cells were
incubated in a humidified atmosphere of 2.5% CO2 at 25
C.
After 5 days, >90% of cells fused into multinucleate myotubes
as previously described (Lo et al., 1993). Reprogramming was
induced by incubating the myotubes in standard growth me-
dium. All inhibitors used in the present manuscript are specified
in Table S1.
In Pmi28 cell cultures, myogenesis was induced as previously
described (Duckmanton et al., 2005). Cells were plated at high
density onto collagen-coated plastic dishes and maintained
for 3 days in differentiation media, consisting of Dulbecco’s
modified Eagle’s medium (Gibco) supplemented with 6% horse
serum (HS; Sigma) and 100 U/ml penicillin/ streptomycin
(Gibco).
Myotube Purification
Myotubes were trypsinized for 1 min, neutralized with media, and
sieved through a 100 mm mesh followed by a 35 mm mesh (Cell
MicroSieve; BioDesign Inc. of New York). Myotubes were retained
on the 35 mmmesh, washed with media to eliminate mononucle-
ates, and collected from the sieve into dishes precoatedwith 0.75%
gelatin.
Pmi28 myotubes were purified by addition of 50 mM Ara-C
(Sigma), which specifically eliminates proliferating cells, to the
differentiation media. The purity of the resulting cultures was
assessed by fluorescence microscopy following incubation with
Hoechst 33258 (2 mg/ml).
Statistical Analysis
Statistical analyses were performed with Prism 4.0, and unpaired
two-tailed t tests were applied unless otherwise stated. Paired
two-tailed t tests were carried out to analyze RT-PCR experiments.
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